Nuzenio

Oncogene

Oncogene news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 4 publisher sources 100/100 entity strength

Latest news

New Research Explores the Cost of Managing Brain Metastases in ALK-Positive Lung Cancer - Oncogene Cancer Research - OncodailyOncodaily · Sat, 08 Aug 2026 22:09:53 GMTFGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma - NatureNature · Fri, 07 Aug 2026 20:39:15 GMTRAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma - NatureNature · Fri, 07 Aug 2026 09:13:30 GMTAKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies - NatureNature · Thu, 06 Aug 2026 20:44:38 GMTIdentification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates - NatureNature · Thu, 06 Aug 2026 11:44:40 GMTDr. Juliet M. Daniel (1964-2026): Dancing to the Rhythm of Kaiso - NatureNature · Wed, 05 Aug 2026 19:56:59 GMTCancer - Oncogenes, Mutations, Treatment - Encyclopedia BritannicaEncyclopedia Britannica · Wed, 05 Aug 2026 05:00:00 GMTThe Future of Antibody-Drug Conjugates and Oncogene-Directed Therapy in NSCLC - OncLiveOncLive · Fri, 31 Jul 2026 12:14:27 GMT

Timeline

Sat, 08 Aug 2026 22:09:53 GMTNew Research Explores the Cost of Managing Brain Metastases in ALK-Positive Lung Cancer - Oncogene Cancer Research - Oncodaily
Fri, 07 Aug 2026 20:39:15 GMTFGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma - Nature
Fri, 07 Aug 2026 09:13:30 GMTRAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma - Nature
Thu, 06 Aug 2026 20:44:38 GMTAKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies - Nature
Thu, 06 Aug 2026 11:44:40 GMTIdentification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates - Nature
Wed, 05 Aug 2026 19:56:59 GMTDr. Juliet M. Daniel (1964-2026): Dancing to the Rhythm of Kaiso - Nature

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncogene.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.